Kang and coworkers [48] also prepared an elaborate series of sulfonated-4-aminochalcones (Figure 82) and tested their activities against the β-secretase (BACE1), an enzyme linked to the onset of Alzheimer’s disease. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.